Key facts
- · Type: New offering first sale 2025-12-11 · Amount sold: $250K · Total offering: $5M · SEC filing
- · Type: Amendment first sale 2023-08-25 · Amount sold: $6.90M · Total offering: $7.50M · SEC filing
- · Type: Filing · SEC filing
Is Mel-Mont Medical, Inc. a real, registered company?
Mel-Mont Medical, Inc. is a registered filer with the SEC (CIK 1832591) and has filed since 2023-09-21. 3 filings are on record, the latest on 2025-12-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
How much has Mel-Mont Medical, Inc. raised?
Its new offerings report $250K sold across 1 offering, as its own filings state.
Run the free check on Mel-Mont Medical, Inc. →
DORAL, FLORIDA
Biotechnology
3
$250K
Every filing
| Filed | Type | Amount sold | Total offering | Records |
|---|---|---|---|---|
| 2025-12-17 | New offering first sale 2025-12-11 | $250K | $5M | SEC filing |
| 2025-12-16 | Amendment first sale 2023-08-25 | $6.90M | $7.50M | SEC filing |
| 2023-09-21 | Filing | — | — | SEC filing |
Watch Mel-Mont Medical, Inc.
Get an email when Mel-Mont Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Mel-Mont Medical, Inc.?
Who to contact
- Frank Melendez — Executive Officer, Director
- Liliana Montes — Executive Officer, Director
- Octavio Gonzalez Paredo — Executive Officer, Director
- Michael Torres — Executive Officer
- Round: Form D filed 2025-12-17
- Amount sold: $250K
- Industry: Biotechnology
- Based: DORAL, FLORIDA
People listed
- Frank Melendez — Executive Officer, Director
- Liliana Montes — Executive Officer, Director
- Octavio Gonzalez Paredo — Executive Officer, Director
- Michael Torres — Executive Officer
- Filing: Form D filed 2025-12-17
- Amount sold: $250K
- Industry group: Biotechnology
- Based: DORAL, FLORIDA
- Entity type: Corporation
We'll show it in your MentionFox inbox when Mel-Mont Medical, Inc. raises, hires or launches. No email unless you switch it on.
Watch Mel-Mont Medical, Inc. →Want the whole picture on Mel-Mont Medical, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Mel-Mont Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Mel-Mont Medical, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
How the total is counted: the amount sold on each new offering, added together. Amendments are left out, because an amendment restates an offering already counted. A filing whose figures have not been read yet shows a dash and adds nothing.
Every figure here is read from Mel-Mont Medical, Inc.'s own filings with the SEC. The people those filings name are on the team page.